Trump Admin Unveils New Medicaid Drug Pricing Initiatives

TL;DR Summary
The Trump administration's CMS is launching a five-year pilot in 2026 to link Medicaid drug prices to lower international prices through a 'Most Favored Nation' model, allowing participating states to negotiate lower prices for certain drugs, amid ongoing debates about its impact on drug costs and rebates.
- Trump admin brings international drug pricing to Medicaid The Hill
- US government launches program to lower Medicaid drug prices Reuters
- CMS Announces New Drug Payment Model Known As Generating Cost Reductions For U.S. Medicaid (Generous) Model To Strengthen Medicaid TradingView
- CMS Announces Voluntary Medicaid MFN Pricing Model NAVLIN DAILY
- CMS Announces GENEROUS Model to Lower Medicaid Drug Prices AJMC
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
4 min
vs 4 min read
Condensed
94%
748 → 47 words
Want the full story? Read the original article
Read on The Hill